Ceftriaxone-Induced Fixed Drug Eruption : First ReportOZKAYA, Esen; MIRZOYEVA, Leyla; JHAISH, Mohammed S. H et al.American journal of clinical dermatology. 2008, Vol 9, Num 5, pp 345-347, issn 1175-0561, 3 p.Article

Spécificité pharmacologique de la ceftriaxone = Pharmacological specificites of ceftriaxoneDRUGEON, H. B.La Presse médicale (1983). 1997, Vol 26, Num 2, pp 78-79, issn 0755-4982Article

Case report: Long-standing complex regional pain syndrome relieved by a cephalosporin antibioticWARE, Mark A; BENNETT, Gary J.Pain (Amsterdam). 2014, Vol 155, Num 7, pp 1412-1415, issn 0304-3959, 4 p.Article

Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemiaARNDT, Patricia A; LEGER, Regina M; GARRATTY, George et al.Transfusion (Philadelphia, PA). 2012, Vol 52, Num 3, pp 602-612, issn 0041-1132, 11 p.Article

Ceftriaxone-induced acute hemolytic anemiaTOBIAN, Aaron A. R; SUE SHIREY, R; SAVAGE, William J et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 8, pp 1647-1648, issn 0041-1132, 2 p.Article

Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patientsSIMON, Nicolas; DUSSOL, Bertrand; SAMPOL, Emmanuelle et al.Clinical pharmacokinetics. 2006, Vol 45, Num 5, pp 493-501, issn 0312-5963, 9 p.Article

Increased Resistance to Multiple Antimicrobials and Altered Resistance Gene Expression in CMY-2-Positive Salmonella enterica following a Simulated Patient Treatment with CeftriaxoneHAMILTON, Russell D; HULSEBUS, Holly J; AKBAR, Samina et al.Applied and environmental microbiology (Print). 2012, Vol 78, Num 22, pp 8062-8066, issn 0099-2240, 5 p.Article

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methodsTAPSALL, John; READ, Phillip; CARMODY, Christopher et al.Journal of medical microbiology. 2009, Vol 58, Num 5, pp 683-687, issn 0022-2615, 5 p.Article

Acidity constants of cefetamet, cefotaxime and ceftriaxone; the effect of the substituent at C3 positionALEKSIC, M; SAVIC, V; POPOVIC, G et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 3-4, pp 752-756, issn 0731-7085, 5 p.Article

Traitement des infections communautaires de l'enfant = Treatment of community-acquired infections in childrenBOURRILLON, A.La Presse médicale (1983). 1997, Vol 26, Num 9, pp 418-419, issn 0755-4982Article

Evaluation of a Potential Clinical Interaction between Ceftriaxone and CalciumSTEADMAN, Emily; RAISCH, Dennis W; BENNETT, Charles L et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 4, pp 1534-1540, issn 0066-4804, 7 p.Article

Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacaeMULLER, A; LOPEZ-LOZANO, J. M; BERTRAND, X et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 1, pp 173-177, issn 0305-7453, 5 p.Article

Stabilité du spectre de la ceftriaxone = Stability of the ceftriaxone spectrumGOLDSTEIN, F. W.La Presse médicale (1983). 1997, Vol 26, Num 3, pp 120-121, issn 0755-4982Article

Concentrations de ceftriaxone (1 000 mg IV) dans les tissus abdominaux après emploi en antibioprophylaxie au cours de la chirurgie pancréatique = Concentrations of ceftriaxone in abdominal tissues after use for antibiotic prophylaxis during pancreatic surgeryMARTIN, C; COTTIN, A; FRANCOIS-GODFROY, N et al.Médecine et maladies infectieuses. 1997, Vol 27, Num JUN, pp 674-677, issn 0399-077XConference Paper

Development of Ceftriaxone Resistance Affects the Virulence Properties of Salmonella enterica Serotype Typhimurium StrainsLIANG LI; YANG, Yu-Rong; LIAO, Xiao-Ping et al.Foodborne pathogens and disease. 2013, Vol 10, Num 1, pp 28-34, issn 1535-3141, 7 p.Article

Ceftriaxone-associated biliary pseudolithiasisRIENSTRA, M; BONTEN, M. J. M; CAILLARD, C. A. J. M et al.Netherlands journal of medicine. 2009, Vol 67, Num 3, pp 113-114, issn 0300-2977, 2 p.Article

Occurrence of ceftriaxone-resistant commensal bacteria on a dairy farm and a poultry farmHUA YANG; DETTMAN, Brittany; BEAM, Jonathan et al.Canadian journal of microbiology. 2006, Vol 52, Num 10, pp 942-950, issn 0008-4166, 9 p.Article

Determination of cefotaxime and ceftriaxone in pharmaceuticals by HPLCMISZTAL, G.Pharmazie. 1998, Vol 53, Num 10, pp 723-724, issn 0031-7144Article

CEFTRIAXONE ALLEVIATES EARLY BRAIN INJURY AFTER SUBARACHNOID HEMORRHAGE BY INCREASING EXCITATORY AMINO ACID TRANSPORTER 2 EXPRESSION VIA THE PI3K/AKT/NF-κB SIGNALING PATHWAYFENG, D; WANG, W; DONG, Y et al.Neuroscience. 2014, Vol 268, pp 21-32, issn 0306-4522, 12 p.Article

Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains Active In Vitro among β-Lactam AgentsMENDES, Rodrigo E; BIEK, Donald; CRITCHLEY, Ian A et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4923-4927, issn 0066-4804, 5 p.Article

Outcomes of Children With Enterobacteriaceae Bacteremia With Reduced Susceptibility to Ceftriaxone: Do the Revised Breakpoints Translate to Improved Patient Outcomes?TAMMA, Pranita D; WU, Harold; GERBER, Jeffrey S et al.The Pediatric infectious disease journal. 2013, Vol 32, Num 9, pp 965-969, issn 0891-3668, 5 p.Article

Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone UsageMCKINNELL, James A; KUNZ, Danielle F; CHAMOT, Eric et al.Infection control and hospital epidemiology. 2012, Vol 33, Num 7, pp 718-724, issn 0899-823X, 7 p.Article

Niveau de preuve du suivi thérapeutique pharmacologique de la ceftriaxone = Level of Evidence for Therapeutic Drug Monitoring of CeftriaxoneDAILLY, Eric; VERDIER, Marie-Clémence; DESLANDES, Guillaume et al.Thérapie (Paris). 2012, Vol 67, Num 2, pp 145-149, issn 0040-5957, 5 p.Article

Bovine Intestinal Bacteria Inactivate and Degrade Ceftiofur and Ceftriaxone with Multiple β-LactamasesDOUG WAGNER, R; JOHNSON, Shemedia J; CERNIGLIA, Carl E et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 4990-4998, issn 0066-4804, 9 p.Article

Evaluation of Contraindicated Drug-Drug Interaction Alerts in a Hospital SettingHATTON, Randy C; ROSENBERG, Amy F; MORRIS, Candice T et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 3, pp 297-308, issn 1060-0280, 12 p.Article